{"DataElement":{"publicId":"6142389","version":"2","preferredName":"Risk Factor Description Type","preferredDefinition":"The text term used to describe a risk factor the patient had at the time of or prior to their diagnosis.","longName":"6140727v1.0:6134102v1.1","context":"GDC","contextVersion":"1","DataElementConcept":{"publicId":"6140727","version":"1","preferredName":"Risk Factor Description","preferredDefinition":"Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury._A written or verbal account, representation, statement, or explanation of something.","longName":"2958324v1.0:2222846v1.0","context":"GDC","contextVersion":"1","ObjectClass":{"publicId":"2958324","version":"1","preferredName":"Risk Factor","preferredDefinition":"Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury.","longName":"C17103","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Risk Factor","conceptCode":"C17103","definition":"Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"77A65C90-9DF8-5754-E040-BB89AD4333DC","latestVersionIndicator":"Yes","beginDate":"2009-11-05","endDate":null,"createdBy":"UMLLOADER_NEWBORN","dateCreated":"2009-11-05","modifiedBy":"ONEDATA","dateModified":"2009-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222846","version":"1","preferredName":"Description","preferredDefinition":"A statement or an account describing something.","longName":"C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6211337-E099-4E34-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"678D9739-A3C5-3C38-E053-F662850AC314","latestVersionIndicator":"Yes","beginDate":"2018-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-16","modifiedBy":"COOPERM","dateModified":"2020-05-28","changeDescription":"Created for caDSR Requests Q12018 Dictionary Updates for Review (supplement) 3.15.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6134102","version":"1.1","preferredName":"Risk Factor Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6134102v1.0","context":"GDC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Cirrhosis","valueDescription":"Cirrhosis","ValueMeaning":{"publicId":"4618018","version":"1","preferredName":"Cirrhosis","longName":"4618018","preferredDefinition":"A chronic degenerative disease of the liver characterized by parenchymal nodularity and fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CFAC-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8A01-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Chronic Systemic Steroid Use","valueDescription":"Chronic Systemic Steroid Use","ValueMeaning":{"publicId":"7465911","version":"1","preferredName":"Chronic Systemic Steroid Use","longName":"7465911","preferredDefinition":"An indication that the subject has been using a systemic steroid at the prescribed dose for a long period of time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Systemic Steroid Use","conceptCode":"C174112","definition":"An indication that the subject has been using a systemic steroid at the prescribed dose for a long period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B89649-8A0E-25AF-E053-4EBD850AB1DC","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8A27-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Chronic Hepatitis","valueDescription":"Chronic Hepatitis","ValueMeaning":{"publicId":"6423725","version":"1","preferredName":"Chronic Hepatitis","longName":"6423725","preferredDefinition":"An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Hepatitis","conceptCode":"C82978","definition":"An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520DCD0-87E0-03F6-E053-F662850A2332","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8A3B-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Cholelithiasis","valueDescription":"Cholelithiasis","ValueMeaning":{"publicId":"6514326","version":"1","preferredName":"Cholelithiasis","longName":"6514326","preferredDefinition":"The presence of calculi in the gallbladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholelithiasis","conceptCode":"C122822","definition":"The presence of calculi in the gallbladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB15-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8A46-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Chlamydia","valueDescription":"Chlamydia","ValueMeaning":{"publicId":"2574150","version":"1","preferredName":"Chlamydia","longName":"2574150","preferredDefinition":"A genus of bacteria within the Chlamydiea phylum that contains only the three species Chlamydia trachomatis, Chlamydia suis, and Chlamydia muridarum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chlamydia","conceptCode":"C76271","definition":"A genus of bacteria within the Chlamydiae phylum that contains only the three species Chlamydia trachomatis, Chlamydia suis, and Chlamydia muridarum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEB3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"ZHANGW","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8A51-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Cancer","valueDescription":"Malignant Neoplasm","ValueMeaning":{"publicId":"2749852","version":"1","preferredName":"Malignant Neoplasm","longName":"2749852","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D47F93B-9A03-2D84-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8A5C-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"BRCA Family History","valueDescription":"Family History of BRCA Mutation","ValueMeaning":{"publicId":"7465913","version":"1","preferredName":"Family History of BRCA Mutation","longName":"7465913","preferredDefinition":"An indication that a variant in a BRCA family gene has been identified in a family member of a subject.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Family History of BRCA Mutation","conceptCode":"C172230","definition":"An indication that a variant in a BRCA family gene has been identified in a family member of a subject.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B89649-8A6A-25AF-E053-4EBD850AB1DC","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8A83-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Birt-Hogg-Dube Syndrome","valueDescription":"Birt-Hogg-Dube Syndrome","ValueMeaning":{"publicId":"6789681","version":"1","preferredName":"Birt-Hogg-Dube Syndrome","longName":"6789681","preferredDefinition":"A rare genetic syndrome with an autosomal dominant pattern of inheritance. It is caused by a mutation in the FLCN gene which encodes the protein folliculin. Clinical signs include multiple benign growths of the skin and lungs that begin to manifest in the second or third decade of life. The clinical course is characterized by the progressive growth of new and existing neoplasms. In those with mutations in both copies of FLCN, the kidneys may also be affected by the growth of benign or malignant neoplasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Birt-Hogg-Dube Syndrome","conceptCode":"C28244","definition":"A rare genetic syndrome with an autosomal dominant pattern of inheritance. It is caused by a mutation in the FLCN gene which encodes the protein folliculin. Clinical signs include multiple benign growths of the skin and lungs that begin to manifest in the second or third decade of life. The clinical course is characterized by the progressive growth of new and existing neoplasms. In those with mutations in both copies of FLCN, the kidneys may also be affected by the growth of benign or malignant neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C154154-5023-48BD-E053-F662850A2BF9","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"ONEDATA","dateModified":"2019-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8A97-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Benign Prostatic Hyperplasia","valueDescription":"Benign Prostatic Hyperplasia","ValueMeaning":{"publicId":"2577137","version":"1","preferredName":"Benign Prostatic Hyperplasia","longName":"2577137","preferredDefinition":"A non-cancerous nodular enlargement of the prostate gland.  It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements.  It is the most common urologic disorder in men, causing blockage of urine flow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Prostatic Hyperplasia","conceptCode":"C2897","definition":"A non-cancerous nodular enlargement of the prostate gland.  It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements.  It is the most common urologic disorder in men, causing blockage of urine flow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA5E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8AA2-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Behcet's Disease","valueDescription":"Behcet Syndrome","ValueMeaning":{"publicId":"2593579","version":"1","preferredName":"Behcet Syndrome","longName":"2593579","preferredDefinition":"Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS, THROMBOPHLEBITIS, gastrointestinal ulcerations, RETINAL VASCULITIS, and OPTIC ATROPHY may occur as well.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Behcet Syndrome","conceptCode":"C34416","definition":"A rare chronic inflammatory disorder of unknown etiology. It is characterized by the development of ulcers in the mouth and genital region and uveitis. Other signs and symptoms include arthritis, deep vein thrombosis and superficial thrombophlebitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28C01CF8-E883-093C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8AB7-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Barrett's Esophagus","valueDescription":"Barrett Esophagus","ValueMeaning":{"publicId":"3210773","version":"1","preferredName":"Barrett Esophagus","longName":"3210773","preferredDefinition":"Esophageal segment lined with columnar metaplastic epithelium which is flat or villiform.  Barrett's epithelium is characterized by two different types of cells: goblet cells and columnar cells.  The symptomatology of Barrett's esophagus is that of gastro-esophageal reflux.  It is the precursor of most esophageal adenocarcinomas.  (WHO, 2000) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Barrett Esophagus","conceptCode":"C2891","definition":"Esophageal lesion lined with columnar metaplastic epithelium which is flat or villiform. Barrett epithelium is characterized by two different types of cells: goblet cells and columnar cells. The symptomatology of Barrett esophagus is that of gastro-esophageal reflux. It is the precursor of most esophageal adenocarcinomas.  (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9D5E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8AC2-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"BAP1 Tumor Predisposition Syndrome","valueDescription":"BAP1 Tumor Predisposition Syndrome","ValueMeaning":{"publicId":"7465915","version":"1","preferredName":"BAP1 Tumor Predisposition Syndrome","longName":"7465915","preferredDefinition":"A syndrome caused by germline mutations in the BAP1 gene. It is inherited in an autosomal dominant pattern. Individuals carrying heterozygous BAP1 mutations have an increased risk of developing various tumor types, most commonly BAP1-inactivated nevi /melanocytomas of the skin, uveal and cutaneous melanomas, peritoneal and pleural mesotheliomas, clear cell renal cell carcinoma, and basal cell carcinoma. (WHO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BAP1 Tumor Predisposition Syndrome","conceptCode":"C172639","definition":"A syndrome caused by germline mutations in the BAP1 gene. It is inherited in an autosomal dominant pattern. Individuals carrying heterozygous BAP1 mutations have an increased risk of developing various tumor types, most commonly BAP1-inactivated nevi /melanocytomas of the skin, uveal and cutaneous melanomas, peritoneal and pleural mesotheliomas, clear cell renal cell carcinoma, and basal cell carcinoma. (WHO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B89649-8AD0-25AF-E053-4EBD850AB1DC","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8AE9-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Bacteroides fragilis","valueDescription":"Bacteroides fragilis","ValueMeaning":{"publicId":"4459559","version":"1","preferredName":"Bacteroides fragilis","longName":"4459559","preferredDefinition":"A species of obligately anaerobic, Gram-negative, rod shaped bacteria assigned to the phylum Bacteroidetes. This species is nonmotile, non-spore forming, indole positive, produces hydrogen sulfide, does not reduce nitrate, hydrolyzes esculin and starch, does not ferment trehalose, melezitose or arabinose, and is penicillin resistant. B. fragilis is commensal and part of the normal human gastrointestinal tract flora, but may become pathogenic in other body regions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bacteroides fragilis","conceptCode":"C86172","definition":"A species of obligately anaerobic, Gram-negative, rod shaped bacteria assigned to the phylum Bacteroidetes. This species is nonmotile, non-spore forming, indole positive, produces hydrogen sulfide, does not reduce nitrate, hydrolyzes esculin and starch, does not ferment trehalose, melezitose or arabinose, and is penicillin resistant. B. fragilis is commensal and part of the normal human gastrointestinal tract flora, but may become pathogenic in other body regions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-4451-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"WONGW","dateCreated":"2014-08-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-06-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B89649-8AF3-25AF-E053-4EBD850AB1DC","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Autoimmune Lymphoproliferative Syndrome (ALPS)","valueDescription":"Autoimmune Lymphoproliferative Syndrome","ValueMeaning":{"publicId":"3210890","version":"1","preferredName":"Autoimmune Lymphoproliferative Syndrome","longName":"3210890","preferredDefinition":"An autoimmune hematologic disorder characterized by autoimmune hemolytic anemia, thrombocytopenia, lymphadenopathy, hepatomegaly and splenomegaly. Patients are at an increased risk of developing Hodgkin and non-Hodgkin lymphomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Lymphoproliferative Syndrome","conceptCode":"C37864","definition":"An autoimmune hematologic disorder characterized by autoimmune hemolytic anemia, thrombocytopenia, lymphadenopathy, hepatomegaly and splenomegaly. Patients are at an increased risk of developing Hodgkin and non-Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B040-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B83A71-3796-676C-E053-4EBD850A7FBB","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Autoimmune Atrophic Chronic Gastritis","valueDescription":"Autoimmune Atrophic Chronic Gastritis","ValueMeaning":{"publicId":"6514325","version":"1","preferredName":"Autoimmune Atrophic Chronic Gastritis","longName":"6514325","preferredDefinition":"Chronic atrophic gastritis that is caused by autoimmune destruction of parietal cells in the stomach resulting in hypochlorhydria and decreased production of intrinsic factor. It is characterized by atrophy of the oxyntic mucosa and enterochromaffin-like (ECL) cell hyperplasia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Atrophic Chronic Gastritis","conceptCode":"C156076","definition":"Chronic atrophic gastritis that is caused by autoimmune destruction of parietal cells in the stomach resulting in hypochlorhydria and decreased production of intrinsic factor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FAD2-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B83A71-37A1-676C-E053-4EBD850A7FBB","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Ataxia-telangiectasia","valueDescription":"Ataxia Telangiectasia Syndrome","ValueMeaning":{"publicId":"2593388","version":"1","preferredName":"Ataxia Telangiectasia Syndrome","longName":"2593388","preferredDefinition":"Rare hereditary disease characterized by extreme sensitivity to ionizing radiation or radiomimetic drugs because of a defect in DNA repair. AT heterozygosity is estimated to occur in more than 2% of the U.S. population; heterozygotes exhibit increased radiation sensitivity and are at increased risk for several types of cancer. The normal version of the gene that is defective in AT appears to activate the p53-dependent response to DNA damage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ataxia Telangiectasia Syndrome","conceptCode":"C2887","definition":"Rare hereditary disease characterized by extreme sensitivity to ionizing radiation or radiomimetic drugs because of a defect in DNA repair. AT heterozygosity is estimated to occur in more than 2% of the U.S. population; heterozygotes exhibit increased radiation sensitivity and are at increased risk for several types of cancer. The normal version of the gene that is defective in AT appears to activate the p53-dependent response to DNA damage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2883B655-AF9E-439B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B83A71-37B6-676C-E053-4EBD850A7FBB","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Alpha-1 Antitrypsin Deficiency","valueDescription":"Alpha-1 Antitrypsin Deficiency","ValueMeaning":{"publicId":"3171840","version":"1","preferredName":"Alpha-1 Antitrypsin Deficiency","longName":"3171840","preferredDefinition":"A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha-1 Antitrypsin Deficiency","conceptCode":"C84397","definition":"A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-0146-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B83A71-37C1-676C-E053-4EBD850A7FBB","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Glomerular Disease","valueDescription":"Glomerular Vascular Disorder","ValueMeaning":{"publicId":"6790020","version":"1","preferredName":"Glomerular Vascular Disorder","longName":"6790020","preferredDefinition":"A disorder that is caused by pathologic changes in the glomerular vasculature.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glomerular Vascular Disorder","conceptCode":"C35605","definition":"A disorder that is caused by pathologic changes in the glomerular vasculature.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C19BB34-7767-2DCA-E053-F662850AE3CF","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"ONEDATA","dateModified":"2019-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CE5B5C-77F4-6697-E053-4EBD850ABAB6","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Gilbert's Syndrome","valueDescription":"Gilbert Syndrome","ValueMeaning":{"publicId":"3211098","version":"1","preferredName":"Gilbert Syndrome","longName":"3211098","preferredDefinition":"An autosomal recessive inherited disorder characterized by unconjugated hyperbilirubinemia, resulting in harmless intermittent jaundice.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gilbert Syndrome","conceptCode":"C84729","definition":"An autosomal recessive inherited disorder characterized by unconjugated hyperbilirubinemia, resulting in harmless intermittent jaundice.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-CD82-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CE5B5C-7809-6697-E053-4EBD850ABAB6","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Gastric Polyp(s)","valueDescription":"Gastric Polyp","ValueMeaning":{"publicId":"6514324","version":"1","preferredName":"Gastric Polyp","longName":"6514324","preferredDefinition":"A polyp that arises from the stomach.  This category includes neoplastic polyps (intestinal-type adenomatous polyps, gastric-type adenomas, and fundic gland polyps), and non-neoplastic polyps (hyperplastic polyps and hamartomatous polyps).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Polyp","conceptCode":"C3954","definition":"A polyp that arises from the stomach.  This category includes neoplastic polyps (intestinal-type adenomatous polyps, gastric-type adenomas, and fundic gland polyps), and non-neoplastic polyps (hyperplastic polyps and hamartomatous polyps).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FAAF-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CE5B5C-7814-6697-E053-4EBD850ABAB6","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Fibrosis","valueDescription":"Fibrosis","ValueMeaning":{"publicId":"4264818","version":"1","preferredName":"Fibrosis","longName":"4264818","preferredDefinition":"The formation of fibrous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosis","conceptCode":"C3044","definition":"The formation of fibrous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FCDE-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.2020 Updated definition to match current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CE5B5C-781F-6697-E053-4EBD850ABAB6","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Epstein-Barr Virus","valueDescription":"Epstein-Barr Virus","ValueMeaning":{"publicId":"5527882","version":"1","preferredName":"Epstein-Barr Virus","longName":"5527882","preferredDefinition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F4C6595-C88A-7E5D-E053-F662850A57F1","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CE5B5C-7834-6697-E053-4EBD850ABAB6","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Epithelial Hyperplasia","valueDescription":"Epithelial Hyperplasia","ValueMeaning":{"publicId":"2947184","version":"1","preferredName":"Epithelial Hyperplasia","longName":"2947184","preferredDefinition":"(ep-ih-THEE-lee-ul) Refers to the cells that line the internal and external surfaces of the body.: An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial","conceptCode":"C13315","definition":"A term that refers to the cells that make up the epithelial tissues.  They are found in the skin, and in the parenchyma, surface and lumen of internal organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hyperplasia","conceptCode":"C3113","definition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74B7048F-DD3F-521B-E040-BB89AD4335A5","latestVersionIndicator":"Yes","beginDate":"2009-09-29","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-29","modifiedBy":"ONEDATA","dateModified":"2009-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CE5B5C-783F-6697-E053-4EBD850ABAB6","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Epithelial Dysplasia","valueDescription":"Intraepithelial Neoplasia","ValueMeaning":{"publicId":"3250497","version":"1","preferredName":"Intraepithelial Neoplasia","longName":"3250497","preferredDefinition":"A precancerous neoplastic process that affects the squamous, glandular, or transitional cell epithelium without evidence of invasion. According to the degree of nuclear atypia, number of mitotic figures, and presence of architectural distortion, it is classified as low grade (mild dysplasia) or high grade (moderate or severe dysplasia).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraepithelial Neoplasia","conceptCode":"C8366","definition":"A precancerous neoplastic process that affects the squamous, glandular, or transitional cell epithelium without evidence of invasion. According to the degree of nuclear atypia, number of mitotic figures, and presence of architectural distortion, it is classified as low grade (mild dysplasia) or high grade (moderate or severe dysplasia).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6F215E6-C692-B293-E040-BB89AD432EF3","latestVersionIndicator":"Yes","beginDate":"2011-06-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-30","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CE5B5C-7854-6697-E053-4EBD850ABAB6","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Endosalpingiosis","valueDescription":"Endosalpingiosis","ValueMeaning":{"publicId":"6690575","version":"1","preferredName":"Endosalpingiosis","longName":"6690575","preferredDefinition":"A benign pathologic process characterized by the transformation of the mesothelium into fallopian tube epithelium.  It occurs in the peritoneum and may affect the serosa surface of the uterus and the adnexa.  It may be asymptomatic or present as pelvic pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peritoneal Endosalpingiosis","conceptCode":"C40121","definition":"A benign pathologic process characterized by the transformation of the mesothelium into fallopian tube epithelium.  It occurs in the peritoneum and may affect the serosa surface of the uterus and the adnexa.  It may be asymptomatic or present as pelvic pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86461630-3953-6318-E053-F662850A9706","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"ONEDATA","dateModified":"2019-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CE5B5C-785F-6697-E053-4EBD850ABAB6","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Endometriosis","valueDescription":"Endometriosis","ValueMeaning":{"publicId":"3210813","version":"1","preferredName":"Endometriosis","longName":"3210813","preferredDefinition":"The growth of functional endometrial tissue in anatomic sites outside the uterine body. It most often occurs in the pelvic organs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometriosis","conceptCode":"C3014","definition":"The growth of functional endometrial tissue in anatomic sites outside the uterine body. It most often occurs in the pelvic organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A444-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CE5B5C-786A-6697-E053-4EBD850ABAB6","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Eczema","valueDescription":"Eczema","ValueMeaning":{"publicId":"3252129","version":"1","preferredName":"Eczema","longName":"3252129","preferredDefinition":"A form of dermatitis characterized by red, itchy, scaly, or crusty patches that can be chronic or intermittent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eczema","conceptCode":"C3001","definition":"A form of dermatitis characterized by red, itchy, scaly, or crusty patches that can be chronic or intermittent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A781D14A-E852-8A44-E040-BB89AD4310FD","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.20 Updated definition with current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CE5B5C-787F-6697-E053-4EBD850ABAB6","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Diverticulitis","valueDescription":"Diverticulitis","ValueMeaning":{"publicId":"2577629","version":"1","preferredName":"Diverticulitis","longName":"2577629","preferredDefinition":"An infection that develops in the diverticula of the intestinal tract. Signs and symptoms include abdominal pain, fever, and leukocytosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diverticulitis","conceptCode":"C26752","definition":"An infection that develops in the diverticula of the intestinal tract. Signs and symptoms include abdominal pain, fever, and leukocytosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FC4A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-08","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.20 Updated definition with current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CBD91A-525E-4A8E-E053-4EBD850AB0D7","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Diabetes, Type I","valueDescription":"Type 1 Diabetes Mellitus","ValueMeaning":{"publicId":"5054471","version":"1","preferredName":"Type 1 Diabetes Mellitus","longName":"5054471","preferredDefinition":"A chronic condition characterized by minimal or absent production of insulin by the pancreas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type 1 Diabetes Mellitus","conceptCode":"C2986","definition":"A chronic condition characterized by minimal or absent production of insulin by the pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25628B4B-6B65-594C-E050-BB89AD430F0C","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CBD91A-5273-4A8E-E053-4EBD850AB0D7","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Diabetes, NOS","valueDescription":"Not Otherwise Specified Diabetes Mellitus","ValueMeaning":{"publicId":"6148979","version":"1","preferredName":"Not Otherwise Specified Diabetes Mellitus","longName":"6148979","preferredDefinition":"Not characterized in any other way.: A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6853938B-5DB4-7948-E053-F662850A1496","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CBD91A-527E-4A8E-E053-4EBD850AB0D7","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Cytomegalovirus (CMV)","valueDescription":"Cytomegalovirus","ValueMeaning":{"publicId":"5527883","version":"1","preferredName":"Cytomegalovirus","longName":"5527883","preferredDefinition":"A genus of the family herpesviridae, subfamily betaherpesvirinae, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytomegalovirus","conceptCode":"C14196","definition":"A genus of the family herpesviridae, subfamily betaherpesvirinae, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F4C6595-C8AD-7E5D-E053-F662850A57F1","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CBD91A-5293-4A8E-E053-4EBD850AB0D7","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Cyst(s)","valueDescription":"Cyst","ValueMeaning":{"publicId":"3271440","version":"1","preferredName":"Cyst","longName":"3271440","preferredDefinition":"A sac-like closed membranous structure that may be empty or contain fluid or amorphous material.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cyst","conceptCode":"C2978","definition":"A sac-like closed membranous structure that may be empty or contain fluid or amorphous material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACE0989A-AAD8-11C3-E040-BB89AD4348AF","latestVersionIndicator":"Yes","beginDate":"2011-09-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CBD91A-52A8-4A8E-E053-4EBD850AB0D7","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Cryptococcal Meningitis","valueDescription":"Cryptococcal Meningitis","ValueMeaning":{"publicId":"7467253","version":"1","preferredName":"Cryptococcal Meningitis","longName":"7467253","preferredDefinition":"A blood borne fungal infection of the membranes surrounding the brain and spinal column (meninges) caused by Cryptococcus, usually C. neoformans or C. gattii. It usually occurs in immunocompromised patients including persons with AIDS, transplant recipients, patients receiving cytotoxic chemotherapy, and patients with hematologic malignancies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cryptococcal Meningitis","conceptCode":"C174113","definition":"A blood borne fungal infection of the membranes surrounding the brain and spinal column (meninges) caused by Cryptococcus, usually C. neoformans or C. gattii. It usually occurs in immunocompromised patients including persons with AIDS, transplant recipients, patients receiving cytotoxic chemotherapy, and patients with hematologic malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1CBD91A-52B6-4A8E-E053-4EBD850AB0D7","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CBD91A-52CF-4A8E-E053-4EBD850AB0D7","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Cowden Syndrome","valueDescription":"Cowden Syndrome","ValueMeaning":{"publicId":"3210989","version":"1","preferredName":"Cowden Syndrome","longName":"3210989","preferredDefinition":"An autosomal dominant hereditary syndrome characterized by a variety of hamartomas and neoplasms including verrucous skin lesions, fibromas of the oral cavity, facial trichilemmomas, hamartomatous colonic polyps, thyroid neoplasms, breast cancer, and dysplastic gangliocytomas of the cerebellum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cowden Syndrome","conceptCode":"C3076","definition":"An autosomal dominant hereditary syndrome characterized by a variety of hamartomas and neoplasms including verrucous skin lesions, fibromas of the oral cavity, facial trichilemmomas, hamartomatous colonic polyps, thyroid neoplasms, breast cancer, and dysplastic gangliocytomas of the cerebellum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-BE3C-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CBD91A-52D9-4A8E-E053-4EBD850AB0D7","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Common variable immune deficiency (CVID)","valueDescription":"Common Variable Immunodeficiency","ValueMeaning":{"publicId":"2579841","version":"1","preferredName":"Common Variable Immunodeficiency","longName":"2579841","preferredDefinition":"A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Variable Immunodeficiency","conceptCode":"C26725","definition":"A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04EE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.20 Updated definition to use current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CBD91A-52EE-4A8E-E053-4EBD850AB0D7","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Colonization, Fungal","valueDescription":"Fungal Colonization","ValueMeaning":{"publicId":"6776704","version":"1","preferredName":"Fungal Colonization","longName":"6776704","preferredDefinition":"Collection of fungal organisms in an anatomic site or medical device.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fungal Colonization","conceptCode":"C82980","definition":"Collection of fungal organisms in an anatomic site or medical device.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC28C2E-F681-17D7-E053-F662850A5C74","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CBD91A-5303-4A8E-E053-4EBD850AB0D7","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Colonization, Bacterial","valueDescription":"Bacterial Colonization","ValueMeaning":{"publicId":"7467255","version":"1","preferredName":"Bacterial Colonization","longName":"7467255","preferredDefinition":"The detection of bacteria in or on an anatomic site, medical device or biospecimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bacterial Colonization","conceptCode":"C171138","definition":"The detection of bacteria in or on an anatomic site, medical device or biospecimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1CBD91A-5311-4A8E-E053-4EBD850AB0D7","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1CBD91A-532A-4A8E-E053-4EBD850AB0D7","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3104212","version":"1","preferredName":"Unknown","longName":"3104212v1.00","preferredDefinition":"Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-06F4-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":"Concept annotated for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B613-3494-E053-4EBD850AF587","beginDate":"2018-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"WAGR syndrome","valueDescription":"Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation Syndrome","ValueMeaning":{"publicId":"3211530","version":"1","preferredName":"Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation Syndrome","longName":"3211530","preferredDefinition":"A very rare congenital condition involving the complex of Wilms' tumor, aniridia, genitourinary abnormalities, and mental retardation. Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation (WAGR) syndrome involves deletions of several adjacent genes in chromosome region 11p13. Two or more of the four conditions must be present for an individual to be diagnosed with WAGR Syndrome. The clinical picture varies, depending upon the combination of abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WAGR Syndrome","conceptCode":"C3718","definition":"A very rare congenital condition involving the complex of Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation. Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation (WAGR) syndrome involves deletions of several adjacent genes in chromosome region 11p13. Two or more of the four conditions must be present for an individual to be diagnosed with WAGR Syndrome. The clinical picture varies, depending upon the combination of abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-0B69-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B61D-3494-E053-4EBD850AF587","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Hemihypertrophy","valueDescription":"Hemihypertrophy","ValueMeaning":{"publicId":"3078440","version":"1","preferredName":"Hemihypertrophy","longName":"3078440","preferredDefinition":"A finding indicating the presence of greater than normal asymmetry between the right and left sides of the body. The asymmetry may be manifested in the entire side or part of it.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemihypertrophy","conceptCode":"C88541","definition":"A finding indicating the presence of greater than normal asymmetry between the right and left sides of the body. The asymmetry may be manifested in the entire side or part of it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85399A6D-D1E3-B88C-E040-BB89AD431518","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B627-3494-E053-4EBD850AF587","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Denys-Drash syndrome","valueDescription":"Denys-Drash Syndrome","ValueMeaning":{"publicId":"3211013","version":"1","preferredName":"Denys-Drash Syndrome","longName":"3211013","preferredDefinition":"A rare congenital syndrome caused by mutations in the WT1 gene. It is characterized by the presence of congenital nephropathy (diffuse mesangial sclerosis), Wilms tumor, and intersex disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Denys-Drash Syndrome","conceptCode":"C84668","definition":"A rare congenital syndrome caused by mutations in the WT1 gene. It is characterized by the presence of congenital nephropathy (diffuse mesangial sclerosis), Wilms tumor, and intersex disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-C17E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B631-3494-E053-4EBD850AF587","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Diabetes, type II","valueDescription":"Type 2 Diabetes Mellitus","ValueMeaning":{"publicId":"2976115","version":"1","preferredName":"Type 2 Diabetes Mellitus","longName":"2976115","preferredDefinition":"A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type 2 Diabetes Mellitus","conceptCode":"C26747","definition":"A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C59A54D-BA0C-5B26-E040-BB89AD432407","latestVersionIndicator":"Yes","beginDate":"2010-01-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-04","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B63B-3494-E053-4EBD850AF587","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Colon polyps","valueDescription":"Colon Polyp","ValueMeaning":{"publicId":"4827926","version":"1","preferredName":"Colon Polyp","longName":"4827926","preferredDefinition":"A polypoid lesion that arises from the colon and protrudes into the lumen.  This group includes adenomatous polyps, serrated polyps, and hamartomatous polyps.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Polyp","conceptCode":"C2954","definition":"A polypoid lesion that arises from the colon and protrudes into the lumen.  This group includes adenomatous polyps, serrated polyps, and hamartomatous polyps.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"166470EB-F37E-9810-E050-BB89AD4311C9","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-18","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B645-3494-E053-4EBD850AF587","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Familial adenomatous polyposis","valueDescription":"Adenomatous Polyposis Coli","ValueMeaning":{"publicId":"2577526","version":"1","preferredName":"Adenomatous Polyposis Coli","longName":"2577526","preferredDefinition":"An autosomal dominant disorder, characterized by the presence of multiple adenomas in the colon and rectum. It is caused by a germline mutation in the adenomatous polyposis coli (APC) gene which is located on the long arm of chromosome 5. The adenomas are most often tubular, and they have the tendency to progress to adenocarcinoma. They can occur throughout the colon, but they tend to concentrate in the rectum and sigmoid colon. The colorectal adenomas are detected during endoscopic examination between the age of 10 and 20 years. The adenomas increase in size and numbers with age, and there is usually progression of one or more adenomas to adenocarcinoma. The mean age of development of adenocarcinoma is about 40 years. Signs include rectal bleeding and mucousy diarrhea.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Familial Adenomatous Polyposis","conceptCode":"C3339","definition":"An autosomal dominant disorder, characterized by the presence of multiple adenomas in the colon and rectum. It is caused by a germline mutation in the adenomatous polyposis coli (APC) gene which is located on the long arm of chromosome 5. The adenomas are most often tubular, and they have the tendency to progress to adenocarcinoma. They can occur throughout the colon, but they tend to concentrate in the rectum and sigmoid colon. The colorectal adenomas are detected during endoscopic examination between the age of 10 and 20 years. The adenomas increase in size and numbers with age, and there is usually progression of one or more adenomas to adenocarcinoma. The mean age of development of adenocarcinoma is about 40 years. Signs include rectal bleeding and mucousy diarrhea.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FBE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"COOPERM","dateModified":"2018-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B64F-3494-E053-4EBD850AF587","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Obesity","valueDescription":"Obesity","ValueMeaning":{"publicId":"2566203","version":"1","preferredName":"Obesity","longName":"2566203","preferredDefinition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Obesity","conceptCode":"C3283","definition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFA8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-23","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-07-23","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B659-3494-E053-4EBD850AF587","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Diet","valueDescription":"Diet","ValueMeaning":{"publicId":"3194139","version":"1","preferredName":"Diet","longName":"3194139","preferredDefinition":"The customary allowance of food and drink taken by a person or an animal from day to day, particularly one especially planned to meet specific requirements of the individual, including or excluding certain items of food; a prescribed course of eating and drinking in which the amount and kind of food, as well as the times at which it is to be taken, are regulated for therapeutic purposes or selected with reference to a particular state of health.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diet","conceptCode":"C15222","definition":"The customary allowance of food and drink taken by a person or an animal from day to day, particularly one especially planned to meet specific requirements of the individual, including or excluding certain items of food; a prescribed course of eating and drinking in which the amount and kind of food, as well as the times at which it is to be taken, are regulated for therapeutic purposes or selected with reference to a particular state of health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D736C73-4C58-8C17-E040-BB89AD432887","latestVersionIndicator":"Yes","beginDate":"2011-03-01","endDate":null,"createdBy":"LUY","dateCreated":"2011-03-01","modifiedBy":"COOPERM","dateModified":"2018-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B663-3494-E053-4EBD850AF587","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Beckwith-Wiedemann","valueDescription":"Beckwith-Wiedemann Syndrome","ValueMeaning":{"publicId":"2967368","version":"1","preferredName":"Beckwith-Wiedemann Syndrome","longName":"2967368","preferredDefinition":"A genetic syndrome caused by abnormalities in chromosome 11.  It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia.  Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, Rhabdomyosarcoma) and adrenal cortex carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beckwith-Wiedemann Syndrome","conceptCode":"C34415","definition":"A genetic syndrome caused by abnormalities in chromosome 11. It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia. Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, rhabdomyosarcoma) and adrenal cortex carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB32307-57DC-1A4F-E040-BB89AD43618C","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B66D-3494-E053-4EBD850AF587","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Fanconi anemia","valueDescription":"Fanconi Anemia","ValueMeaning":{"publicId":"5651022","version":"1","preferredName":"Fanconi Anemia","longName":"5651022","preferredDefinition":"A rare inherited disorder in which the bone marrow does not make blood cells. It is usually diagnosed in children between 2 and 15 years old. Symptoms include frequent infections, easy bleeding, and extreme tiredness. People with Fanconi anemia may have a small skeleton and brown spots on the skin. They also have an increased risk of developing certain types of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fanconi Anemia","conceptCode":"C62505","definition":"An autosomal recessive genetic disorder characterized by bone marrow failure, skeletal abnormalities, and an increased incidence of the development of neoplasias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"479020AD-0CB9-3909-E053-F662850A62CA","latestVersionIndicator":"Yes","beginDate":"2017-02-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-02","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B677-3494-E053-4EBD850AF587","beginDate":"2017-10-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Gorlin syndrome","valueDescription":"Nevoid Basal Cell Carcinoma Syndrome","ValueMeaning":{"publicId":"3210902","version":"1","preferredName":"Nevoid Basal Cell Carcinoma Syndrome","longName":"3210902","preferredDefinition":"An autosomal dominant genetic syndrome caused by abnormalities in the PTCH gene.  It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida).  Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nevoid Basal Cell Carcinoma Syndrome","conceptCode":"C2892","definition":"An autosomal dominant genetic syndrome caused by abnormalities in the PTCH and SUFU gene. It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida). Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B1D8-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B681-3494-E053-4EBD850AF587","beginDate":"2017-10-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Li-Fraumeni syndrome","valueDescription":"Li-Fraumeni Syndrome","ValueMeaning":{"publicId":"3211225","version":"1","preferredName":"Li-Fraumeni Syndrome","longName":"3211225","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome caused by an alteration in the p53 tumor suppressor gene.  It is characterized by the development of malignant neoplasms at various anatomic sites.  The malignant neoplasms associated with Li-Fraumeni syndrome include adrenal cortex carcinoma, astrocytic tumors, colorectal carcinoma, gastric carcinoma, malignant breast neoplasms, medulloblastoma, osteosarcoma, and soft tissue sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Li-Fraumeni Syndrome","conceptCode":"C3476","definition":"An autosomal dominant cancer predisposition syndrome caused by germline mutations of the TP53 gene. It is associated with breast carcinoma, choroid plexus carcinoma, adrenal cortex carcinoma, astrocytic tumors, medulloblastoma, soft tissue sarcoma, osteosarcoma, and leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-DF6B-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B68B-3494-E053-4EBD850AF587","beginDate":"2017-10-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Lynch syndrome","valueDescription":"Hereditary Non-Polyposis Colon Cancer","ValueMeaning":{"publicId":"2716424","version":"1","preferredName":"Hereditary Non-Polyposis Colon Cancer","longName":"2716424","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma.  Patients often develop colorectal carcinomas at an early age (mean, 45 years).  In the majority of the cases the lesions arise from the proximal colon.  At the molecular level, high-frequency microsatellite instability is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lynch Syndrome","conceptCode":"C8494","definition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41B659B0-44F3-5521-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B695-3494-E053-4EBD850AF587","beginDate":"2017-10-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B69F-3494-E053-4EBD850AF587","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Rubinstein-Taybi syndrome","valueDescription":"Rubinstein-Taybi Syndrome","ValueMeaning":{"publicId":"3211427","version":"1","preferredName":"Rubinstein-Taybi Syndrome","longName":"3211427","preferredDefinition":"A rare genetic syndrome mapped to chromosome 16p13.3 and associated with mutations in the CREBBP gene.  It is characterized by mental and growth retardation, distinctive facial features (prominent nose, low-set ears, microcephaly, and small mouth), and broad thumbs and great toes.  Patients are at an increased risk of developing benign and malignant neoplasms, including nervous system neoplasms and malignant lymphoproliferative disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rubinstein-Taybi Syndrome","conceptCode":"C75466","definition":"A rare genetic syndrome mapped to chromosome 16p13.3 and associated with mutations in the CREBBP gene. It is characterized by mental and growth retardation, distinctive facial features (prominent nose, low-set ears, microcephaly, and small mouth), and broad thumbs and great toes. Patients are at an increased risk of developing benign and malignant neoplasms, including nervous system neoplasms and malignant lymphoproliferative disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-FC39-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B6A9-3494-E053-4EBD850AF587","beginDate":"2017-10-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Turcot syndrome","valueDescription":"Turcot Syndrome","ValueMeaning":{"publicId":"6002212","version":"1","preferredName":"Turcot Syndrome","longName":"6002212","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome caused by mutations in the PMS2, MLH1, MSH2, or APC genes. There are two types described, type 1, characterized by the presence of glioblastoma and often associated with hereditary nonpolyposis colorectal carcinoma, and type 2, characterized by the presence of medulloblastoma and familiar adenomatous polyposis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Turcot Syndrome","conceptCode":"C3938","definition":"An autosomal dominant hereditary neoplastic syndrome caused by mutations in the PMS2, MLH1, MSH2, or APC genes. There are two types described, type 1, characterized by the presence of glioblastoma and often associated with hereditary nonpolyposis colorectal carcinoma, and type 2, characterized by the presence of medulloblastoma and familiar adenomatous polyposis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E1CD4-4E37-160D-E053-F662850A7005","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B6B3-3494-E053-4EBD850AF587","beginDate":"2017-10-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Wasp","valueDescription":"Wasp Venom Allergy","ValueMeaning":{"publicId":"7465884","version":"1","preferredName":"Wasp Venom Allergy","longName":"7465884","preferredDefinition":"An allergic reaction triggered by being exposed to wasp venom following a wasp sting.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wasp Venom Allergy","conceptCode":"C172321","definition":"An allergic reaction triggered by being exposed to wasp venom following a wasp sting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B6C5-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B6DE-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Seafood","valueDescription":"Shellfish Allergy","ValueMeaning":{"publicId":"7465886","version":"1","preferredName":"Shellfish Allergy","longName":"7465886","preferredDefinition":"An allergic reaction triggered by exposure to allergens found in foods containing molluscs, crustaceans or echinoderms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Shellfish Allergy","conceptCode":"C172320","definition":"An allergic reaction triggered by exposure to allergens found in foods containing molluscs, crustaceans or echinoderms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B6EB-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B704-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Processed Foods","valueDescription":"Processed Food Allergy","ValueMeaning":{"publicId":"7465887","version":"1","preferredName":"Processed Food Allergy","longName":"7465887","preferredDefinition":"Processed Food Allergy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B70E-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B727-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Nuts","valueDescription":"Nut Allergy","ValueMeaning":{"publicId":"7465888","version":"1","preferredName":"Nut Allergy","longName":"7465888","preferredDefinition":"Nut Allergy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B731-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B74A-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Mold or Dust","valueDescription":"Mold or Dust Allergy","ValueMeaning":{"publicId":"7465890","version":"1","preferredName":"Mold or Dust Allergy","longName":"7465890","preferredDefinition":"An allergic reaction triggered by exposure to airborne allergens expressed by dust mites or molds.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mold or Dust Allergy","conceptCode":"C172306","definition":"An allergic reaction triggered by exposure to airborne allergens expressed by dust mites or molds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B757-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B770-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Meat","valueDescription":"Meat Allergy","ValueMeaning":{"publicId":"7465892","version":"1","preferredName":"Meat Allergy","longName":"7465892","preferredDefinition":"An allergic reaction triggered by exposure to foodborne allergens found in meat.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meat Allergy","conceptCode":"C172317","definition":"An allergic reaction triggered by exposure to foodborne allergens found in meat.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B77D-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B796-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Fruit","valueDescription":"Fruit Allergy","ValueMeaning":{"publicId":"7465894","version":"1","preferredName":"Fruit Allergy","longName":"7465894","preferredDefinition":"An allergic reaction triggered by exposure to foodborne allergens found in fruit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fruit Allergy","conceptCode":"C172316","definition":"An allergic reaction triggered by exposure to foodborne allergens found in fruit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B7A3-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B7BC-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Food, NOS","valueDescription":"Not Otherwise Specified Food Allergy","ValueMeaning":{"publicId":"7465896","version":"1","preferredName":"Not Otherwise Specified Food Allergy","longName":"7465896","preferredDefinition":"Not characterized in any other way.: An allergic reaction triggered by exposure to allergens found in food; exposure can occur through the skin, respiratory tract or digestive tract.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Food Allergy","conceptCode":"C172304","definition":"An allergic reaction triggered by exposure to allergens found in food; exposure can occur through the skin, respiratory tract or digestive tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B7CA-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B7E3-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Eggs","valueDescription":"Egg Allergy","ValueMeaning":{"publicId":"7465898","version":"1","preferredName":"Egg Allergy","longName":"7465898","preferredDefinition":"An allergic reaction triggered by exposure to foodborne allergens found in eggs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Egg Allergy","conceptCode":"C172313","definition":"An allergic reaction triggered by exposure to foodborne allergens found in eggs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B7F0-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B809-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Dog","valueDescription":"Dog Allergy","ValueMeaning":{"publicId":"7465900","version":"1","preferredName":"Dog Allergy","longName":"7465900","preferredDefinition":"An allergic reaction triggered by exposure to allergens expressed by dogs, includes allergenic factors found in canine saliva and dander.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dog Allergy","conceptCode":"C172311","definition":"An allergic reaction triggered by exposure to allergens expressed by dogs, includes allergenic factors found in canine saliva and dander.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B816-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B82F-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Dairy or Lactose","valueDescription":"Dairy Product or Lactose Intolerance Allergy","ValueMeaning":{"publicId":"7465901","version":"1","preferredName":"Dairy Product or Lactose Intolerance Allergy","longName":"7465901","preferredDefinition":"Raw and processed or manufactured milk and milk-derived products. These are usually from cows (bovine) but are also from goats, sheep, reindeer, and water buffalo.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The disease state resulting from the absence of lactase enzyme in the musocal cells of the gastrointestinal tract, and therefore an inability to break down the disaccharide lactose in milk for absorption from the gastrointestinal tract. It is manifested by indigestion of a mild nature to severe diarrhea. It may be due to inborn defect genetically conditioned or may be acquired.: An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dairy Product","conceptCode":"C413","definition":"Food made from the milk of some mammals, most commonly cows, goats and sheep.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Lactose Intolerance","conceptCode":"C3154","definition":"Inability to fully digest and absorb lactose due to limited or no lactase activity in the small intestine.  Congenital intolerance is inherited following an autosomal recessive pattern but is rare. It is more often due to a gradual decline of lactase production in adulthood following the ingestion of fewer lactose-containing foods or secondary to an intestinal mucosal brush-border injury. Prevalence is highest among Asians, Native Americans and Africans. Clinical signs include abdominal cramping, bloating, flatulence and diarrhea following the dietary intake of lactose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Allergic Reaction","conceptCode":"C114476","definition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B83D-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"COOPERM","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B856-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Cat","valueDescription":"Cat Allergy","ValueMeaning":{"publicId":"7465903","version":"1","preferredName":"Cat Allergy","longName":"7465903","preferredDefinition":"An allergic reaction triggered by exposure to allergens expressed by cats, includes allergenic factors found in feline saliva and dander.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cat Allergy","conceptCode":"C172310","definition":"An allergic reaction triggered by exposure to allergens expressed by cats, includes allergenic factors found in feline saliva and dander.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B863-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B87C-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Bee","valueDescription":"Bee Venom Allergy","ValueMeaning":{"publicId":"7465905","version":"1","preferredName":"Bee Venom Allergy","longName":"7465905","preferredDefinition":"An allergic reaction triggered by being exposed to bee venom following a bee sting.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bee Venom Allergy","conceptCode":"C172308","definition":"An allergic reaction triggered by being exposed to bee venom following a bee sting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B889-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B8A2-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Ant","valueDescription":"Venomous Ant Bite Allergy","ValueMeaning":{"publicId":"7465907","version":"1","preferredName":"Venomous Ant Bite Allergy","longName":"7465907","preferredDefinition":"An allergic reaction triggered by exposure to ant venom, usually as a result of being bitten by a fire ant (Solenopsis spp.).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Venomous Ant Bite Allergy","conceptCode":"C172307","definition":"An allergic reaction triggered by exposure to ant venom, usually as a result of being bitten by a fire ant (Solenopsis spp.).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B8AF-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B8C8-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Allergy, Animal, NOS","valueDescription":"Not Otherwise Specified Animal Allergy","ValueMeaning":{"publicId":"7465909","version":"1","preferredName":"Not Otherwise Specified Animal Allergy","longName":"7465909","preferredDefinition":"Not characterized in any other way.: An allergic reaction triggered by exposure to animal-associated allergens, includes allergenic factors in venom, saliva and dander.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Animal Allergy","conceptCode":"C172303","definition":"An allergic reaction triggered by exposure to animal-associated allergens, includes allergenic factors in venom, saliva and dander.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B8D6-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B8EF-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Alcoholic Liver Disease","valueDescription":"Alcoholic Liver Disease","ValueMeaning":{"publicId":"3210771","version":"1","preferredName":"Alcoholic Liver Disease","longName":"3210771","preferredDefinition":"A disorder caused by damage to the liver parenchyma due to alcohol consumption. It may present with an acute onset or follow a chronic course, leading to cirrhosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcoholic Liver Disease","conceptCode":"C34783","definition":"A disorder caused by damage to the liver parenchyma due to alcohol consumption. It may present with an acute onset or follow a chronic course, leading to cirrhosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9D1A-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B8F9-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Alcohol Consumption","valueDescription":"Alcohol Consumption","ValueMeaning":{"publicId":"5025993","version":"1","preferredName":"Alcohol Consumption","longName":"5025993","preferredDefinition":"consumption of liquids containing ethanol; includes the behavior of drinking the alcohol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcohol Consumption","conceptCode":"C16273","definition":"Consumption of liquids containing ethanol, including the behaviors associated with drinking the alcohol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20D29B95-82D4-6C89-E050-BB89AD437D47","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B903-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Adenosis (Atypical Adenomatous Hyperplasia)","valueDescription":"Adenosis","ValueMeaning":{"publicId":"5629883","version":"1","preferredName":"Adenosis","longName":"5629883","preferredDefinition":"Any disease or disorder of a gland, characterized by abnormal development or enlargement of the gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosis","conceptCode":"C120861","definition":"Any disease or disorder of a gland, characterized by abnormal development or enlargement of the gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4665E9A6-5654-662A-E053-F662850ACD24","latestVersionIndicator":"Yes","beginDate":"2017-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B7D94A-B918-3494-E053-4EBD850AF587","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Lymphocytic Meningitis","valueDescription":"Lymphocytic Meningitis","ValueMeaning":{"publicId":"7469668","version":"1","preferredName":"Lymphocytic Meningitis","longName":"7469668","preferredDefinition":"Meningitis in which lymphocytes predominate in the cerebrospinal fluid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphocytic Meningitis","conceptCode":"C174114","definition":"Meningitis in which lymphocytes predominate in the cerebrospinal fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1D01C86-6DAD-4369-E053-4EBD850A62AE","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6DC6-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Low Grade Dysplasia","valueDescription":"Low Grade Dysplasia","ValueMeaning":{"publicId":"6514328","version":"1","preferredName":"Low Grade Dysplasia","longName":"6514328","preferredDefinition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be low.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Dysplasia","conceptCode":"C156084","definition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be low.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB5B-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6DD0-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Iron Overload","valueDescription":"Iron Overload","ValueMeaning":{"publicId":"2945194","version":"1","preferredName":"Iron Overload","longName":"2945194","preferredDefinition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iron Overload","conceptCode":"C78393","definition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"745580E8-4272-8FA9-E040-BB89AD433702","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6DDB-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Intestinal Metaplasia","valueDescription":"Intestinal Metaplasia","ValueMeaning":{"publicId":"3250504","version":"1","preferredName":"Intestinal Metaplasia","longName":"3250504","preferredDefinition":"A morphologic finding indicating the replacement of epithelial tissue outside the intestines by intestinal-type epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intestinal Metaplasia","conceptCode":"C8360","definition":"A morphologic finding indicating the replacement of epithelial tissue outside the intestines by intestinal-type epithelium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6F215E6-C73C-B293-E040-BB89AD432EF3","latestVersionIndicator":"Yes","beginDate":"2011-06-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-30","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6DE6-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Inflammation, Hyperkeratosis","valueDescription":"Hyperkeratosis","ValueMeaning":{"publicId":"3400906","version":"1","preferredName":"Hyperkeratosis","longName":"3400906","preferredDefinition":"Hypertrophy of the outermost layer of the epidermis. It maybe caused by physical or chemical irritants, irradiation, infection, or neoplastic processes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperkeratosis","conceptCode":"C35541","definition":"Hypertrophy of the outermost layer of the epidermis. It may be caused by physical or chemical irritants, irradiation, infection, or neoplastic processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA832F68-6997-A591-E040-BB89AD432A24","latestVersionIndicator":"Yes","beginDate":"2012-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6DFB-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Inflammation","valueDescription":"Inflammation","ValueMeaning":{"publicId":"2581231","version":"1","preferredName":"Inflammation","longName":"2581231","preferredDefinition":"A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A5C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-17","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6E06-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hypospadias","valueDescription":"Hypospadias","ValueMeaning":{"publicId":"7469669","version":"1","preferredName":"Hypospadias","longName":"7469669","preferredDefinition":"A congenital abnormality in which the external urethral orifice is on the underside of the penis. In a minority of cases it is associated with other genitourinary abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypospadias","conceptCode":"C40341","definition":"A congenital abnormality in which the external urethral orifice is on the underside of the penis. In a minority of cases it is associated with other genitourinary abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1D01C86-6E11-4369-E053-4EBD850A62AE","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6E2A-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Human Papillomavirus Infection","valueDescription":"Human Papillomavirus Infection","ValueMeaning":{"publicId":"7469670","version":"1","preferredName":"Human Papillomavirus Infection","longName":"7469670","preferredDefinition":"An infectious process caused by a human papillomavirus. This infection can cause abnormal tissue growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Papillomavirus Infection","conceptCode":"C27851","definition":"An infectious process caused by a human papillomavirus. This infection can cause abnormal tissue growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1D01C86-6E36-4369-E053-4EBD850A62AE","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6E4F-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"HIV","valueDescription":"Human Immunodeficiency Virus","ValueMeaning":{"publicId":"4395759","version":"1","preferredName":"Human Immunodeficiency Virus","longName":"4395759","preferredDefinition":"Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Immunodeficiency Virus","conceptCode":"C14219","definition":"The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D7D1-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6E59-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"High-grade Prostatic Intraepithelial Neoplasia (PIN)","valueDescription":"High Grade Prostatic Intraepithelial Neoplasia","ValueMeaning":{"publicId":"2581149","version":"1","preferredName":"High Grade Prostatic Intraepithelial Neoplasia","longName":"2581149","preferredDefinition":"Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts. The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoloplasmic ratio. The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform. The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Prostatic Intraepithelial Neoplasia","conceptCode":"C5541","definition":"Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts.  The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoplasmic ratio.  The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform.  The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6E6E-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hereditary Breast Cancer","valueDescription":"Hereditary Breast Carcinoma","ValueMeaning":{"publicId":"6689281","version":"1","preferredName":"Hereditary Breast Carcinoma","longName":"6689281","preferredDefinition":"Breast carcinoma that has developed in relatives of patients with history of breast carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Breast Carcinoma","conceptCode":"C4503","definition":"Breast carcinoma that has developed in relatives of patients with history of breast carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86225E2F-3E9B-2B99-E053-F662850A5B1B","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6E83-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hepatitis, NOS","valueDescription":"Not Otherwise Specified Hepatitis","ValueMeaning":{"publicId":"7469671","version":"1","preferredName":"Not Otherwise Specified Hepatitis","longName":"7469671","preferredDefinition":"Not characterized in any other way.: Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hepatitis","conceptCode":"C3095","definition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1D01C86-6E90-4369-E053-4EBD850A62AE","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6EA9-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hematologic Disorder, NOS","valueDescription":"Not Otherwise Specified Hematologic and Lymphocytic Disorder","ValueMeaning":{"publicId":"7469672","version":"1","preferredName":"Not Otherwise Specified Hematologic and Lymphocytic Disorder","longName":"7469672","preferredDefinition":"Not characterized in any other way.: A neoplastic or non-neoplastic disorder that affects the production and proliferation of the hematopoietic cells including lymphoid cells, the synthesis of hemoglobin, and/or the mechanisms of coagulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hematopoietic and Lymphoid Cell Disorder","conceptCode":"C26323","definition":"A non-neoplastic or neoplastic disorder that arises from the hematopoietic and lymphoid cells. Representative examples include disorders that affect the synthesis of hemoglobin, coagulation disorders, leukemias, and lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1D01C86-6EB6-4369-E053-4EBD850A62AE","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6ECF-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Helicobacter Pylori-Associated Gastritis","valueDescription":"Helicobacter Pylori-Associated Gastritis","ValueMeaning":{"publicId":"6270556","version":"1","preferredName":"Helicobacter Pylori-Associated Gastritis","longName":"6270556","preferredDefinition":"Inflammation of the stomach that is associated with Helicobacter Pylori.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Helicobacter Pylori-Associated Gastritis","conceptCode":"C27121","definition":"Inflammation of the stomach that is associated with Helicobacter Pylori.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA5693B-FA62-4FB6-E053-F662850A1EAE","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6ED9-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Headache","valueDescription":"Headache","ValueMeaning":{"publicId":"2719266","version":"1","preferredName":"Headache","longName":"2719266","preferredDefinition":"Pain in various parts of the head, not confined to the area of distribution of any nerve.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Headache","conceptCode":"C34661","definition":"Pain in various parts of the head, not confined to the area of distribution of any nerve.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4351B20D-E735-1D1B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6EE4-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hay Fever","valueDescription":"Seasonal Allergic Rhinitis","ValueMeaning":{"publicId":"4827914","version":"1","preferredName":"Seasonal Allergic Rhinitis","longName":"4827914","preferredDefinition":"Allergic rhinitis caused by outdoor allergens.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seasonal Allergic Rhinitis","conceptCode":"C92188","definition":"Allergic rhinitis caused by outdoor allergens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"166470EB-F11A-9810-E050-BB89AD4311C9","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6EF9-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hashimoto's Thyroiditis","valueDescription":"Hashimoto Thyroiditis","ValueMeaning":{"publicId":"3211123","version":"1","preferredName":"Hashimoto Thyroiditis","longName":"3211123","preferredDefinition":"An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hashimoto Thyroiditis","conceptCode":"C27191","definition":"An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-D10E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6F04-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hemochromatosis","valueDescription":"Hemochromatosis","ValueMeaning":{"publicId":"3171844","version":"1","preferredName":"Hemochromatosis","longName":"3171844","preferredDefinition":"An inherited metabolic disorder characterized by iron accumulation in the tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Hemochromatosis","conceptCode":"C84481","definition":"An inherited metabolic disorder characterized by iron accumulation in the tissues.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-0192-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6F0F-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hepatic Encephalopathy","valueDescription":"Hepatic Encephalopathy","ValueMeaning":{"publicId":"7469674","version":"1","preferredName":"Hepatic Encephalopathy","longName":"7469674","preferredDefinition":"A constellation of signs and symptoms characterized by changes in personality, consciousness, and reflexes, resulting from neuropsychiatric abnormalities secondary to liver failure without evidence of other brain disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatic Encephalopathy","conceptCode":"C79596","definition":"A constellation of signs and symptoms characterized by changes in personality, consciousness, and reflexes, resulting from neuropsychiatric abnormalities secondary to liver failure without evidence of other brain disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1D01C86-6F1C-4369-E053-4EBD850A62AE","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6F35-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hepatitis B Infection","valueDescription":"Hepatitis B Infection","ValueMeaning":{"publicId":"4761116","version":"1","preferredName":"Hepatitis B Infection","longName":"4761116v1.00","preferredDefinition":"A viral infection caused by the hepatitis B virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Infection","conceptCode":"C3097","definition":"A viral infection caused by the hepatitis B virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12375748-2AE9-8D8D-E050-BB89AD430CF5","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-03-26","modifiedBy":"GDEEN","dateModified":"2023-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6F49-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hepatitis C Infection","valueDescription":"Hepatitis C","ValueMeaning":{"publicId":"2975596","version":"1","preferredName":"Hepatitis C","longName":"2975596","preferredDefinition":"An RNA virus, causes non-A and non-B Hepatitis and liver cancer","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Infection","conceptCode":"C3098","definition":"A viral infection caused by the hepatitis C virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C084539-0F01-6AD0-E040-BB89AD43189B","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6F54-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hereditary Kidney Oncocytoma","valueDescription":"Hereditary Kidney Oncocytoma","ValueMeaning":{"publicId":"6789677","version":"1","preferredName":"Hereditary Kidney Oncocytoma","longName":"6789677","preferredDefinition":"An inherited condition characterized by the development of kidney oncocytomas which are often bilateral and multifocal.  This condition may be connected to Birt-Hogg-Dube syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Kidney Oncocytoma","conceptCode":"C8960","definition":"An inherited condition characterized by the development of kidney oncocytomas which are often bilateral and multifocal.  This condition may be connected to Birt-Hogg-Dube syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C154154-4FCC-48BD-E053-F662850A2BF9","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"ONEDATA","dateModified":"2019-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6F68-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hereditary Leiomyomatosis and Renal Cell Carcinoma","valueDescription":"Hereditary Leiomyomatosis and Renal Cell Cancer","ValueMeaning":{"publicId":"6789030","version":"1","preferredName":"Hereditary Leiomyomatosis and Renal Cell Cancer","longName":"6789030","preferredDefinition":"An autosomal dominant inherited syndrome caused by germline mutations in the FH gene. It is characterized by predisposition to leiomyomas of the skin and uterus, renal cell carcinoma, and leiomyosarcoma of the uterus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Leiomyomatosis and Renal Cell Carcinoma","conceptCode":"C51302","definition":"An autosomal dominant inherited syndrome caused by germline mutations in the FH gene. It is characterized by predisposition to renal cell carcinoma, leiomyomas of the skin and uterus, and leiomyosarcoma of the uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDAECC9-DB33-02E9-E053-F662850AABB5","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6F7D-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hereditary Ovarian Carcinoma","valueDescription":"Hereditary Ovarian Carcinoma","ValueMeaning":{"publicId":"6689279","version":"1","preferredName":"Hereditary Ovarian Carcinoma","longName":"6689279","preferredDefinition":"Ovarian carcinoma that has developed in relatives of patients that have a history of ovarian carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Ovarian Carcinoma","conceptCode":"C36102","definition":"Ovarian carcinoma that has developed in relatives of patients that have a history of ovarian carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86225E2F-3E75-2B99-E053-F662850A5B1B","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6F92-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hereditary Papillary Renal Cell Carcinoma","valueDescription":"Hereditary Papillary Renal Cell Carcinoma","ValueMeaning":{"publicId":"3248532","version":"1","preferredName":"Hereditary Papillary Renal Cell Carcinoma","longName":"3248532","preferredDefinition":"A familiar carcinoma inherited in an autosomal dominant trait.  It is characterized by the development of multiple, bilateral papillary renal cell carcinomas.  The carcinomas range from microscopic lesions to clinically symptomatic tumors.  It is associated with activating mutations of the MET oncogene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Papillary Renal Cell Carcinoma","conceptCode":"C9222","definition":"A familial carcinoma inherited in an autosomal dominant trait.  It is characterized by the development of multiple, bilateral papillary renal cell carcinomas.  The carcinomas range from microscopic lesions to clinically symptomatic tumors.  It is associated with activating mutations of the MET oncogene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-B9AC-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6FA6-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hereditary Prostate Carcinoma","valueDescription":"Hereditary Prostate Carcinoma","ValueMeaning":{"publicId":"7469676","version":"1","preferredName":"Hereditary Prostate Carcinoma","longName":"7469676","preferredDefinition":"Prostate carcinoma that has developed in relatives of patients with a history of prostate carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Prostate Carcinoma","conceptCode":"C103817","definition":"Prostate carcinoma that has developed in relatives of patients with a history of prostate carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1D01C86-6FB4-4369-E053-4EBD850A62AE","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6FCD-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"Hereditary Renal Cell Carcinoma","valueDescription":"Hereditary Renal Cell Carcinoma","ValueMeaning":{"publicId":"6789679","version":"1","preferredName":"Hereditary Renal Cell Carcinoma","longName":"6789679","preferredDefinition":"Renal cell carcinoma that has developed in relatives of patients with history of renal cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Renal Cell Carcinoma","conceptCode":"C39789","definition":"Renal cell carcinoma that has developed in relatives of patients with history of renal cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C154154-4FFD-48BD-E053-F662850A2BF9","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"ONEDATA","dateModified":"2019-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6FE1-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"},{"value":"High Grade Dysplasia","valueDescription":"High Grade Dysplasia","ValueMeaning":{"publicId":"6514327","version":"1","preferredName":"High Grade Dysplasia","longName":"6514327","preferredDefinition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be high.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Dysplasia","conceptCode":"C156083","definition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB38-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1D01C86-6FEC-4369-E053-4EBD850A62AE","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B7D94A-B5FD-3494-E053-4EBD850AF587","latestVersionIndicator":"Yes","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"JKNABLE","dateModified":"2022-06-21","changeDescription":"Created for caDSR Requests Q12018 Dictionary Updates for Review (supplement) 3.15.18 mc Versioned to extend max length and add PVs to match the GDC data dictionary. 10.15.20 mc","administrativeNotes":"6/21/22 Released per qtrly review; CDE released. jk","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"10429357","version":"1","longName":"GDC (Genomic Data Commons)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"14506028","version":"1","longName":"Reviewed 2023","context":"CRDC"}]},{"publicId":"13574489","version":"1","longName":"Childhood Cancer Data Initiative","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"13594092","version":"1","longName":"Participant","context":"Pediatric Cancer"},{"publicId":"13596245","version":"1","longName":"Follow Up","context":"Pediatric Cancer"}]},{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"6059563","version":"1","longName":"Followup","context":"GDC"}]}],"AlternateNames":[{"name":"risk_factor","type":"CCDI Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"Risk factor","type":"Preferred Question Text","description":"Risk factor","url":null,"context":"GDC"}],"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA570876-08EF-2AFE-E053-4EBD850A1172","latestVersionIndicator":"Yes","beginDate":"2022-03-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2022-03-16","modifiedBy":"FINCHAMB","dateModified":"2023-09-25","changeDescription":"3/16/22 jk versioned to use new VD with updated PV list. 3.15.18 mc Created for caDSR Requests Q12018 Dictionary Updates for Review (supplement)","administrativeNotes":"9/15/23 Added CCDI alts, CSI. mr","unresolvedIssues":null,"deletedIndicator":"No"}}